{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T06:03:59Z","timestamp":1780121039286,"version":"3.54.0"},"reference-count":134,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82501797"],"award-info":[{"award-number":["82501797"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.pbb.2025.174099","type":"journal-article","created":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T09:39:29Z","timestamp":1757756369000},"page":"174099","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Advancements in psychedelic research: Effects, mechanisms, and therapeutic potential as emerging antidepressants"],"prefix":"10.1016","volume":"256","author":[{"given":"Xian-Qiang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De-Nong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Shan","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu-Xin","family":"Zong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Kun","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.pbb.2025.174099_bb0005","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1021\/acsptsci.1c00018","article-title":"Naturalistic use of mescaline is associated with self-reported psychiatric improvements and enduring positive life changes","volume":"4","author":"Agin-Liebes","year":"2021","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"7","key":"10.1016\/j.pbb.2025.174099_bb0010","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/cncr.35010","article-title":"Psilocybin-assisted group therapy in patients with cancer diagnosed with a major depressive disorder","volume":"130","author":"Agrawal","year":"2024","journal-title":"Cancer"},{"key":"10.1016\/j.pbb.2025.174099_bb0015","article-title":"Potential therapeutic effects of an ayahuasca-inspired N,N-DMT and harmine formulation: a controlled trial in healthy subjects","volume":"14","author":"Aicher","year":"2023","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.pbb.2025.174099_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2019.01234","article-title":"Modulation of serum brain-derived neurotrophic factor by a single dose of Ayahuasca: observation from a randomized controlled trial","volume":"10","author":"de Almeida","year":"2019","journal-title":"Front. Psychol."},{"key":"10.1016\/j.pbb.2025.174099_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2018.00536","article-title":"N, N-dimethyltryptamine (DMT), an endogenous hallucinogen: past, present, and future research to determine its role and function","volume":"12","author":"Barker","year":"2018","journal-title":"Front. Neurosci."},{"issue":"23","key":"10.1016\/j.pbb.2025.174099_bb0030","doi-asserted-by":"crossref","first-page":"9870","DOI":"10.1073\/pnas.0700436104","article-title":"Mechanism of the 5-hydroxytryptamine 2A receptor-mediated facilitation of synaptic activity in prefrontal cortex","volume":"104","author":"Beique","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.pbb.2025.174099_bb0035","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.biopsych.2018.09.031","article-title":"The impact of stress and major depressive disorder on hippocampal and medial prefrontal cortex morphology","volume":"85","author":"Belleau","year":"2019","journal-title":"Biol. Psychiatry"},{"issue":"11","key":"10.1016\/j.pbb.2025.174099_bb0040","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1038\/npp.2017.84","article-title":"The therapeutic potential of psychedelic drugs: past, present, and future","volume":"42","author":"Carhart-Harris","year":"2017","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"10.1016\/j.pbb.2025.174099_bb0045","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S2215-0366(16)30065-7","article-title":"Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study","volume":"3","author":"Carhart-Harris","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"10.1016\/j.pbb.2025.174099_bb0050","doi-asserted-by":"crossref","first-page":"13187","DOI":"10.1038\/s41598-017-13282-7","article-title":"Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms","volume":"7","author":"Carhart-Harris","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.pbb.2025.174099_bb0055","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00213-017-4771-x","article-title":"Psilocybin with psychological support for treatment-resistant depression: six-month follow-up","volume":"235","author":"Carhart-Harris","year":"2018","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.pbb.2025.174099_bb0060","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1192\/bjp.2018.66","article-title":"Treatment-resistant depression and peripheral C-reactive protein","volume":"214","author":"Chamberlain","year":"2019","journal-title":"Br. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.pbb.2025.174099_bb0065","doi-asserted-by":"crossref","first-page":"11540","DOI":"10.1038\/s41598-017-11065-8","article-title":"Molecular mechanisms underlying the involvement of the sigma-1 receptor in methamphetamine-mediated microglial polarization","volume":"7","author":"Chao","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pbb.2025.174099_bb0070","article-title":"Microrna-specific targets for neuronal plasticity, neurotransmitters, neurotrophic factors, and gut microbes in the pathogenesis and therapeutics of depression","volume":"136","author":"Chen","year":"2024","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"8","key":"10.1016\/j.pbb.2025.174099_bb0075","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1007\/s11011-021-00854-w","article-title":"Correction to: toxicity of ayahuasca after 28 days daily exposure and effects on monoamines and brain-derived neurotrophic factor (BDNF) in brain of Wistar rats","volume":"36","author":"Colaco","year":"2021","journal-title":"Metab. Brain Dis."},{"issue":"10312","key":"10.1016\/j.pbb.2025.174099_bb0080","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/S0140-6736(21)02143-7","article-title":"Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic","volume":"398","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.pbb.2025.174099_bb0085","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jad.2024.02.089","article-title":"Predicting the outcome of psilocybin treatment for depression from baseline fMRI functional connectivity","volume":"353","author":"Copa","year":"2024","journal-title":"J. Affect. Disord."},{"issue":"11","key":"10.1016\/j.pbb.2025.174099_bb0090","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.3390\/ijms17111953","article-title":"d-Lysergic acid diethylamide (LSD) as a model of psychosis: mechanism of action and pharmacology","volume":"17","author":"Danilo","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.pbb.2025.174099_bb0095","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/jamapsychiatry.2020.3285","article-title":"Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial","volume":"78","author":"Davis","year":"2021","journal-title":"JAMA Psychiatr."},{"issue":"4","key":"10.1016\/j.pbb.2025.174099_bb0100","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/s41591-022-01744-z","article-title":"Increased global integration in the brain after psilocybin therapy for depression","volume":"28","author":"Daws","year":"2022","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.pbb.2025.174099_bb0105","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2020705118","article-title":"Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitatory neurotransmission","volume":"118","author":"De Gregorio","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.pbb.2025.174099_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2025.111278","article-title":"Psychedelics in neuroinflammation: mechanisms and therapeutic potential","volume":"137","author":"de Deus","year":"2025","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.pbb.2025.174099_bb0115","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10787-020-00777-5","article-title":"The anti-inflammatory role of SSRI and SNRI in the treatment of depression: a review of human and rodent research studies","volume":"29","author":"Dionisie","year":"2021","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.pbb.2025.174099_bb0120","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.bbi.2012.11.013","article-title":"Prenatal stress increases the expression of proinflammatory cytokines and exacerbates the inflammatory response to LPS in the hippocampal formation of adult male mice","volume":"28","author":"Diz-Chaves","year":"2013","journal-title":"Brain Behav. Immun."},{"issue":"11","key":"10.1016\/j.pbb.2025.174099_bb0125","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1038\/npp.2016.82","article-title":"LSD acutely impairs fear recognition and enhances emotional empathy and sociality","volume":"41","author":"Dolder","year":"2016","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.pbb.2025.174099_bb0130","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s00213-011-2434-x","article-title":"Pharmacology of ayahuasca administered in two repeated doses","volume":"219","author":"Dos Santos","year":"2012","journal-title":"Psychopharmacology"},{"issue":"5","key":"10.1016\/j.pbb.2025.174099_bb0135","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A meta-analysis of cytokines in major depression","volume":"67","author":"Dowlati","year":"2010","journal-title":"Biol. Psychiatry"},{"issue":"10","key":"10.1016\/j.pbb.2025.174099_bb0140","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1038\/s41386-022-01344-y","article-title":"Exploratory study of the dose-related safety, tolerability, and efficacy of dimethyltryptamine (DMT) in healthy volunteers and major depressive disorder","volume":"47","author":"D\u2019Souza","year":"2022","journal-title":"Neuropsychopharmacology"},{"issue":"24","key":"10.1016\/j.pbb.2025.174099_bb0145","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1097\/CM9.0000000000002647","article-title":"Psilocybin facilitates fear extinction in mice by promoting hippocampal neuroplasticity","volume":"136","author":"Du","year":"2023","journal-title":"Chin. Med. J."},{"issue":"2","key":"10.1016\/j.pbb.2025.174099_bb0150","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3109\/07853890903485730","article-title":"Brain-derived neurotrophic factor and suicide pathogenesis","volume":"42","author":"Dwivedi","year":"2010","journal-title":"Ann. Med."},{"issue":"8","key":"10.1016\/j.pbb.2025.174099_bb0155","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.cub.2016.02.010","article-title":"Increased global functional connectivity correlates with LSD-induced ego dissolution","volume":"26","author":"Enzo","year":"2016","journal-title":"Curr. Biol."},{"issue":"6","key":"10.1016\/j.pbb.2025.174099_bb0160","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/s41386-025-02091-6","article-title":"Rapid and sustained antidepressant effects of vaporized N,N-dimethyltryptamine: a phase 2a clinical trial in treatment-resistant depression","volume":"50","author":"Falchi-Carvalho","year":"2025","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.pbb.2025.174099_bb0165","article-title":"The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode network","volume":"10","author":"Fernanda","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.pbb.2025.174099_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116790","article-title":"5-HT(2) receptor activation alleviates airway inflammation and structural remodeling in a chronic mouse asthma model","volume":"236","author":"Flanagan","year":"2019","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.pbb.2025.174099_bb0175","doi-asserted-by":"crossref","first-page":"13444","DOI":"10.1038\/s41598-019-49987-0","article-title":"Activation of 5-HT(2) receptors reduces inflammation in vascular tissue and cholesterol levels in high-fat diet-fed apolipoprotein E knockout mice","volume":"9","author":"Flanagan","year":"2019","journal-title":"Sci. Rep."},{"issue":"19","key":"10.1016\/j.pbb.2025.174099_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/ijms251910373","article-title":"Are BDNF and stress levels related to antidepressant response?","volume":"25","author":"Flores-Ramos","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"5916","key":"10.1016\/j.pbb.2025.174099_bb0185","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1126\/science.1166127","article-title":"The hallucinogen N,N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator","volume":"323","author":"Fontanilla","year":"2009","journal-title":"Science"},{"issue":"16","key":"10.1016\/j.pbb.2025.174099_bb0190","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1021\/acschemneuro.2c00170","article-title":"Tolerance and cross-tolerance among psychedelic and nonpsychedelic 5-HT(2A) receptor agonists in mice","volume":"13","author":"de la Fuente Revenga","year":"2022","journal-title":"ACS Chem. Neurosci."},{"issue":"17","key":"10.1016\/j.pbb.2025.174099_bb0195","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1097\/00001756-199812010-00024","article-title":"Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action","volume":"9","author":"FX","year":"1998","journal-title":"Neuroreport."},{"key":"10.1016\/j.pbb.2025.174099_bb0200","first-page":"4","article-title":"Classical hallucinogens: An Introductory Overview","volume":"146","author":"Glennon","year":"1994","journal-title":"NIDA Res"},{"issue":"12","key":"10.1016\/j.pbb.2025.174099_bb0205","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1017\/S0033291712000591","article-title":"Short-term SSRI treatment normalises amygdala hyperactivity in depressed patients","volume":"42","author":"Godlewska","year":"2012","journal-title":"Psychol. Med."},{"issue":"18","key":"10.1016\/j.pbb.2025.174099_bb0210","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJMoa2206443","article-title":"Single-dose psilocybin for a treatment-resistant episode of major depression","volume":"387","author":"Goodwin","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pbb.2025.174099_bb0215","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jad.2023.01.108","article-title":"Single-dose psilocybin for a treatment-resistant episode of major depression: impact on patient-reported depression severity, anxiety, function, and quality of life","volume":"327","author":"Goodwin","year":"2023","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pbb.2025.174099_bb0220","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jad.2024.12.061","article-title":"The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression","volume":"372","author":"Goodwin","year":"2025","journal-title":"J. Affect. Disord."},{"issue":"12","key":"10.1016\/j.pbb.2025.174099_bb0225","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1177\/0269881116675513","article-title":"Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial","volume":"30","author":"Griffiths","year":"2016","journal-title":"J. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.pbb.2025.174099_bb0230","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.euroneuro.2018.03.016","article-title":"Psilocybin modulates functional connectivity of the amygdala during emotional face discrimination","volume":"28","author":"Grimm","year":"2018","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.pbb.2025.174099_bb0235","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/02698811211073759","article-title":"Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: prospective 12-month follow-up","volume":"36","author":"Gukasyan","year":"2022","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pbb.2025.174099_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2021.113344","article-title":"Stimulation of astrocytic sigma-1 receptor is sufficient to ameliorate inflammation- induced depression","volume":"410","author":"Guo","year":"2021","journal-title":"Behav. Brain Res."},{"issue":"9","key":"10.1016\/j.pbb.2025.174099_bb0245","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1007\/s00213-025-06777-z","article-title":"The evolution of N, N-dimethyltryptamine: from metabolic pathways to brain connectivity","volume":"242","author":"Gupta","year":"2025","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2025.174099_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2024.108641","article-title":"Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated with major depression and neurodegenerative diseases","volume":"258","author":"Haniff","year":"2024","journal-title":"Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.pbb.2025.174099_bb0265","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1007\/s00406-024-01770-7","article-title":"Are \u201cmystical experiences\u201d essential for antidepressant actions of ketamine and the classic psychedelics?","volume":"275","author":"Hashimoto","year":"2025","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.pbb.2025.174099_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109610","article-title":"Psychedelics: threshold of a therapeutic revolution","volume":"236","author":"Heal","year":"2023","journal-title":"Neuropharmacology"},{"issue":"17","key":"10.1016\/j.pbb.2025.174099_bb0275","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2022489118","article-title":"Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice","volume":"118","author":"Hesselgrave","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1\u20132","key":"10.1016\/j.pbb.2025.174099_bb0250","first-page":"53","article-title":"How LSD originated","volume":"11","author":"Hofmann","year":"1979","journal-title":"J. Psychoactive Drugs"},{"key":"10.1016\/j.pbb.2025.174099_bb0255","series-title":"LSD: My Problem Child","author":"Hofmann","year":"2013"},{"issue":"3","key":"10.1016\/j.pbb.2025.174099_bb0280","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF02159243","article-title":"Psilocybin, a psychotropic substance from the Mexican mushroom Psilicybe mexicana Heim","volume":"14","author":"Hofmann","year":"1958","journal-title":"Experientia"},{"key":"10.1016\/j.pbb.2025.174099_bb0285","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1146\/annurev.me.15.020164.001223","volume":"15","author":"Hollister","year":"1964","journal-title":"Chemical Psychoses. Annu Rev Med."},{"issue":"1","key":"10.1016\/j.pbb.2025.174099_bb0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/WNF.0000000000000618","article-title":"Efficacy of minocycline in depression: a systematic review and meta-analysis","volume":"48","author":"Huang","year":"2025","journal-title":"Clin. Neuropharmacol."},{"issue":"1","key":"10.1016\/j.pbb.2025.174099_bb0295","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12888-020-02553-9","article-title":"Minocycline as adjunctive treatment for treatment-resistant depression: study protocol for a double blind, placebo-controlled, randomized trial (MINDEP2)","volume":"20","author":"Husain","year":"2020","journal-title":"BMC Psychiatry"},{"issue":"2","key":"10.1016\/j.pbb.2025.174099_bb0300","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1021\/acsptsci.0c00099","article-title":"Low doses of LSD acutely increase BDNF blood plasma levels in healthy volunteers","volume":"4","author":"Hutten","year":"2021","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"1","key":"10.1016\/j.pbb.2025.174099_bb0305","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1124\/pharmrev.120.000056","article-title":"Psychedelics in psychiatry: neuroplastic, immunomodulatory, and neurotransmitter mechanisms","volume":"73","author":"Inserra","year":"2021","journal-title":"Pharmacol. Rev."},{"issue":"4","key":"10.1016\/j.pbb.2025.174099_bb0310","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1177\/0269881116628430","article-title":"Decreased mental time travel to the past correlates with default-mode network disintegration under lysergic acid diethylamide","volume":"30","author":"Jana","year":"2016","journal-title":"J. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.pbb.2025.174099_bb0315","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1038\/s41598-020-61169-x","article-title":"Effects of ayahuasca on mental health and quality of life in naive users: a longitudinal and cross-sectional study combination","volume":"10","author":"Jimenez-Garrido","year":"2020","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.pbb.2025.174099_bb0320","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1007\/s13311-017-0542-y","article-title":"Potential therapeutic effects of psilocybin","volume":"14","author":"Johnson","year":"2017","journal-title":"Neurotherapeutics"},{"issue":"5","key":"10.1016\/j.pbb.2025.174099_bb0325","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1074\/mcp.M113.036558","article-title":"Quantitative phosphoproteomics unravels biased phosphorylation of serotonin 2A receptor at Ser280 by hallucinogenic versus nonhallucinogenic agonists","volume":"13","author":"Karaki","year":"2014","journal-title":"Mol. Cell. Proteomics"},{"issue":"4","key":"10.1016\/j.pbb.2025.174099_bb0330","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1021\/acsmedchemlett.0c00048","article-title":"Psilocybin therapeutic research: the present and future paradigm","volume":"11","author":"Kargbo","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"issue":"2","key":"10.1016\/j.pbb.2025.174099_bb0335","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/01.yic.0000194375.42589.c3","article-title":"Onset of action of escitalopram compared with other antidepressants: results of a pooled analysis","volume":"21","author":"Kasper","year":"2006","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.pbb.2025.174099_bb0340","article-title":"Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor","volume":"7","author":"Katrin","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.pbb.2025.174099_bb0345","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.721537","article-title":"Persisting effects of Ayahuasca on empathy, creative thinking, decentering, personality, and well-being","volume":"12","author":"Kiraga","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.pbb.2025.174099_bb0350","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.917199","article-title":"Psychedelics, mystical experience, and therapeutic efficacy: a systematic review","volume":"13","author":"Ko","year":"2022","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.pbb.2025.174099_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2024.109949","article-title":"Single administration of a psychedelic [(R)-DOI] influences coping strategies to an escapable social stress","volume":"252","author":"Krupp","year":"2024","journal-title":"Neuropharmacology"},{"issue":"8","key":"10.1016\/j.pbb.2025.174099_bb0360","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1056\/NEJM196802222780806","article-title":"Lysergic acid diethylamide","volume":"278","author":"L","year":"1968","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pbb.2025.174099_bb0365","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.intimp.2018.12.001","article-title":"Exosomes derived from mesenchymal stem cells attenuate inflammation and demyelination of the central nervous system in EAE rats by regulating the polarization of microglia","volume":"67","author":"Li","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"10","key":"10.1016\/j.pbb.2025.174099_bb0370","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1080\/15548627.2023.2213984","article-title":"Impaired lipophagy induced-microglial lipid droplets accumulation contributes to the buildup of TREM1 in diabetes-associated cognitive impairment","volume":"19","author":"Li","year":"2023","journal-title":"Autophagy"},{"issue":"9\u201310","key":"10.1016\/j.pbb.2025.174099_bb0375","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1007\/s00213-016-4453-0","article-title":"Alterations of consciousness and mystical-type experiences after acute LSD in humans","volume":"234","author":"Liechti","year":"2017","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.pbb.2025.174099_bb0380","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s10020-024-01013-4","article-title":"Effects of psychedelics on neurogenesis and broader neuroplasticity: a systematic review","volume":"30","author":"Lima da Cruz","year":"2024","journal-title":"Mol. Med."},{"key":"10.1016\/j.pbb.2025.174099_bb0385","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jad.2014.06.012","article-title":"Influence of 5-HTR2A genetic polymorphisms on the efficacy of antidepressants in the treatment of major depressive disorder: a meta-analysis","volume":"168","author":"Lin","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pbb.2025.174099_bb0390","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/7854_2017_478","article-title":"Hallucinogens and serotonin 5-HT(2A) receptor-mediated signaling pathways","volume":"36","author":"Lopez-Gimenez","year":"2018","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.pbb.2025.174099_bb0395","article-title":"The immunomodulatory effects of classical psychedelics: a systematic review of preclinical studies","volume":"111139","author":"Low","year":"2024","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"11","key":"10.1016\/j.pbb.2025.174099_bb0400","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1016\/j.celrep.2018.05.022","article-title":"Psychedelics promote structural and functional neural plasticity","volume":"23","author":"Ly","year":"2018","journal-title":"Cell Rep."},{"issue":"4","key":"10.1016\/j.pbb.2025.174099_bb0405","doi-asserted-by":"crossref","first-page":"e1084","DOI":"10.1038\/tp.2017.54","article-title":"Acute effects of LSD on amygdala activity during processing of fearful stimuli in healthy subjects","volume":"7","author":"M","year":"2017","journal-title":"Transl. Psychiatry"},{"issue":"5","key":"10.1016\/j.pbb.2025.174099_bb0410","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3390\/ijms17050733","article-title":"Pathogenetic and therapeutic applications of tumor necrosis factor-alpha (TNF-alpha) in major depressive disorder: a systematic review","volume":"17","author":"Ma","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"0","key":"10.1016\/j.pbb.2025.174099_bb0415","article-title":"The link between depression and physical symptoms","volume":"6","author":"Madhukar","year":"2005","journal-title":"Prim. Care Companion J. Clin. Psychiatry"},{"issue":"11","key":"10.1016\/j.pbb.2025.174099_bb0420","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1517\/14728222.2012.718331","article-title":"Targeting IL-1 in depression","volume":"16","author":"Maes","year":"2012","journal-title":"Expert Opin. Ther. Targets"},{"issue":"3","key":"10.1016\/j.pbb.2025.174099_bb0425","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/0269881114568040","article-title":"Peak experiences and the afterglow phenomenon: when and how do therapeutic effects of hallucinogens depend on psychedelic experiences?","volume":"29","author":"Majic","year":"2015","journal-title":"J. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.pbb.2025.174099_bb0430","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.pharmthera.2004.03.002","article-title":"Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges","volume":"102","author":"McKenna","year":"2004","journal-title":"Pharmacol. Ther."},{"issue":"9","key":"10.1016\/j.pbb.2025.174099_bb0435","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1038\/s41380-022-01652-1","article-title":"Blood-based biomarkers of antidepressant response to ketamine and esketamine: a systematic review and meta-analysis","volume":"27","author":"Medeiros","year":"2022","journal-title":"Mol. Psychiatry"},{"issue":"2","key":"10.1016\/j.pbb.2025.174099_bb0440","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1177\/0269881119895520","article-title":"Therapeutic mechanisms of psilocybin: changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression","volume":"34","author":"Mertens","year":"2020","journal-title":"J. Psychopharmacol."},{"issue":"8","key":"10.1016\/j.pbb.2025.174099_bb0445","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1001\/jamapsychiatry.2013.1111","article-title":"Autoimmune diseases and severe infections as risk factors for mood disorders: a nationwide study","volume":"70","author":"Michael","year":"2013","journal-title":"JAMA Psychiat."},{"issue":"9","key":"10.1016\/j.pbb.2025.174099_bb0450","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.3390\/ijms20092283","article-title":"The role of chemokines in the pathophysiology of major depressive disorder","volume":"20","author":"Milenkovic","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.pbb.2025.174099_bb0455","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060863","article-title":"Stimulation of the sigma-1 receptor by DHEA enhances synaptic efficacy and neurogenesis in the hippocampal dentate gyrus of olfactory bulbectomized mice","volume":"8","author":"Moriguchi","year":"2013","journal-title":"PLoS One"},{"issue":"4\u20135","key":"10.1016\/j.pbb.2025.174099_bb0460","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1159\/000496622","article-title":"Do immune dysregulations and oxidative damage drive mood and psychotic disorders?","volume":"79","author":"Morrens","year":"2020","journal-title":"Neuropsychobiology"},{"issue":"4","key":"10.1016\/j.pbb.2025.174099_bb0465","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s00213-019-05445-3","article-title":"Ayahuasca\u2019s \u2018afterglow\u2019: improved mindfulness and cognitive flexibility in ayahuasca drinkers","volume":"237","author":"Murphy-Beiner","year":"2020","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.pbb.2025.174099_bb0470","first-page":"356","article-title":"Psychedelics","volume":"68","author":"N","year":"2016","journal-title":"Pharmacol. Rev."},{"issue":"5","key":"10.1016\/j.pbb.2025.174099_bb0475","doi-asserted-by":"crossref","DOI":"10.1007\/s11011-025-01650-6","article-title":"Immunomodulatory and behavioral effects of ayahuasca and N, N-dimethyltryptamine in a rat model of lipopolysaccharide-induced depression","volume":"40","author":"do Nascimento Sousa","year":"2025","journal-title":"Metab. Brain Dis."},{"issue":"3","key":"10.1016\/j.pbb.2025.174099_bb0480","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/02791072.2002.10399962","article-title":"The serotonergic system and mysticism: could LSD and the nondrug-induced mystical experience share common neural mechanisms?","volume":"34","author":"Neil","year":"2002","journal-title":"J. Psychoactive Drugs"},{"key":"10.1016\/j.pbb.2025.174099_bb0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109232","article-title":"Psychedelics as potent anti-inflammatory therapeutics","volume":"219","author":"Nichols","year":"2022","journal-title":"Neuropharmacology"},{"issue":"8","key":"10.1016\/j.pbb.2025.174099_bb0490","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1177\/02698811221101061","article-title":"Antidepressant effects of a psychedelic experience in a large prospective naturalistic sample","volume":"36","author":"Nygart","year":"2022","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pbb.2025.174099_bb0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2022.114148","article-title":"Nootropic effects of LSD: behavioral, molecular and computational evidence","volume":"356","author":"Ornelas","year":"2022","journal-title":"Exp. Neurol."},{"issue":"4","key":"10.1016\/j.pbb.2025.174099_bb0500","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1017\/S0033291718001356","article-title":"Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial","volume":"49","author":"Palhano-Fontes","year":"2019","journal-title":"Psychol. Med."},{"issue":"6","key":"10.1016\/j.pbb.2025.174099_bb0505","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1001\/jamaoncol.2023.0248","article-title":"Enrollment barriers for molecular targeted trials","volume":"9","author":"Paydary","year":"2023","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.pbb.2025.174099_bb0510","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.884703","article-title":"Changes in mental health, wellbeing and personality following ayahuasca consumption: results of a naturalistic longitudinal study","volume":"13","author":"Perkins","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.pbb.2025.174099_bb0515","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.pnpbp.2014.04.013","article-title":"Converging translational evidence for the involvement of the serotonin 2A receptor gene in major depressive disorder","volume":"54","author":"Petit","year":"2014","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"8","key":"10.1016\/j.pbb.2025.174099_bb0520","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.biopsych.2014.04.010","article-title":"Psilocybin-induced decrease in amygdala reactivity correlates with enhanced positive mood in healthy volunteers","volume":"78","author":"Rainer","year":"2015","journal-title":"Biol. Psychiatry"},{"issue":"9","key":"10.1016\/j.pbb.2025.174099_bb0525","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1001\/jama.2023.14530","article-title":"Single-dose psilocybin treatment for major depressive disorder: a randomized clinical trial","volume":"330","author":"Raison","year":"2023","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.pbb.2025.174099_bb0530","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3390\/ijms22020835","article-title":"A single dose of psilocybin increases synaptic density and decreases 5-HT(2A) receptor density in the pig brain","volume":"22","author":"Raval","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pbb.2025.174099_bb0535","article-title":"Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression","volume":"8","author":"Roseman","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.pbb.2025.174099_bb0540","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.neuropharm.2017.12.041","article-title":"Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression","volume":"142","author":"Roseman","year":"2018","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.pbb.2025.174099_bb0545","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1176\/appi.ajp.20220835","article-title":"Antidepressant effects of psilocybin in the absence of psychedelic effects","volume":"180","author":"Rosenblat","year":"2023","journal-title":"Am. J. Psychiatry"},{"issue":"12","key":"10.1016\/j.pbb.2025.174099_bb0550","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1177\/0269881116675512","article-title":"Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial","volume":"30","author":"Ross","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pbb.2025.174099_bb0555","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2019.00862","article-title":"Neuronal sigma-1 receptors: signaling functions and protective roles in neurodegenerative diseases","volume":"13","author":"Ryskamp","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.pbb.2025.174099_bb0560","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.nbd.2018.12.022","article-title":"Pridopidine stabilizes mushroom spines in mouse models of Alzheimer\u2019s disease by acting on the sigma-1 receptor","volume":"124","author":"Ryskamp","year":"2019","journal-title":"Neurobiol. Dis."},{"issue":"6","key":"10.1016\/j.pbb.2025.174099_bb0565","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1038\/s41380-024-02439-2","article-title":"Lasting dynamic effects of the psychedelic 2,5-dimethoxy-4-iodoamphetamine ((+\/\u2212)-DOI) on cognitive flexibility","volume":"29","author":"Sabanovic","year":"2024","journal-title":"Mol. Psychiatry"},{"issue":"2","key":"10.1016\/j.pbb.2025.174099_bb0570","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00213-017-4733-3","article-title":"Long-lasting subjective effects of LSD in normal subjects","volume":"235","author":"Schmid","year":"2018","journal-title":"Psychopharmacology"},{"issue":"8","key":"10.1016\/j.pbb.2025.174099_bb0575","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.biopsych.2014.11.015","article-title":"Acute effects of lysergic acid diethylamide in healthy subjects","volume":"78","author":"Schmid","year":"2015","journal-title":"Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.pbb.2025.174099_bb0580","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/s41386-024-01794-6","article-title":"Antidepressant-like effects of psychedelics in a chronic despair mouse model: is the 5-HT(2A) receptor the unique player?","volume":"49","author":"Sekssaoui","year":"2024","journal-title":"Neuropsychopharmacology"},{"issue":"16","key":"10.1016\/j.pbb.2025.174099_bb0585","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1016\/j.neuron.2021.06.008","article-title":"Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo","volume":"109","author":"Shao","year":"2021","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.pbb.2025.174099_bb0590","doi-asserted-by":"crossref","first-page":"271","DOI":"10.31887\/DCNS.2008.10.3\/shkennedy","article-title":"Core symptoms of major depressive disorder: relevance to diagnosis and treatment","volume":"10","author":"Sidney","year":"2008","journal-title":"Dialogues Clin. Neurosci."},{"issue":"7","key":"10.1016\/j.pbb.2025.174099_bb0595","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1177\/02698811231154852","article-title":"Psilocybin-assisted therapy for major depressive disorder: an exploratory placebo-controlled, fixed-order trial","volume":"37","author":"Sloshower","year":"2023","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pbb.2025.174099_bb0600","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2015.00358","article-title":"Psychedelics and immunomodulation: novel approaches and therapeutic opportunities","volume":"6","author":"Szabo","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.pbb.2025.174099_bb0605","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2016.00423","article-title":"The endogenous hallucinogen and trace amine N,N-dimethyltryptamine (DMT) displays potent protective effects against hypoxia via sigma-1 receptor activation in human primary iPSC-derived cortical neurons and microglia-like immune cells","volume":"10","author":"Szabo","year":"2016","journal-title":"Front. Neurosci."},{"issue":"11","key":"10.1016\/j.pbb.2025.174099_bb0610","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/BF02157378","article-title":"Dimethyltryptamin: its metabolism in man; the relation to its psychotic effect to the serotonin metabolism","volume":"12","author":"Szara","year":"1956","journal-title":"Experientia"},{"key":"10.1016\/j.pbb.2025.174099_bb0615","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2024.105723","article-title":"Polarization to M1-type microglia in the hippocampus is involved in depression-like behavior in a mouse model of olfactory dysfunction","volume":"175","author":"Takahashi","year":"2024","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.pbb.2025.174099_bb0620","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.bbi.2014.05.007","article-title":"Evidence for increased microglial priming and macrophage recruitment in the dorsal anterior cingulate white matter of depressed suicides","volume":"42","author":"Torres-Platas","year":"2014","journal-title":"Brain Behav. Immun."},{"issue":"10","key":"10.1016\/j.pbb.2025.174099_bb0625","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1007\/s00213-018-4988-3","article-title":"Sub-acute and long-term effects of ayahuasca on affect and cognitive thinking style and their association with ego dissolution","volume":"235","author":"Uthaug","year":"2018","journal-title":"Psychopharmacology"},{"issue":"7","key":"10.1016\/j.pbb.2025.174099_bb0630","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1007\/s00213-021-05817-8","article-title":"A placebo-controlled study of the effects of ayahuasca, set and setting on mental health of participants in ayahuasca group retreats","volume":"238","author":"Uthaug","year":"2021","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2025.174099_bb0635","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109294","article-title":"Mescaline: the forgotten psychedelic","volume":"222","author":"Vamvakopoulou","year":"2023","journal-title":"Neuropharmacology"},{"issue":"11","key":"10.1016\/j.pbb.2025.174099_bb0640","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1111\/bph.16315","article-title":"Ayahuasca-enhanced extinction of fear behaviour: role of infralimbic cortex 5-HT(2A) and 5-HT(1A) receptors","volume":"181","author":"Werle","year":"2024","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pbb.2025.174099_bb0645","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.euroneuro.2023.07.003","article-title":"The potential of psychedelics for the treatment of Alzheimer\u2019s disease and related dementias","volume":"76","author":"Winkelman","year":"2023","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"5","key":"10.1016\/j.pbb.2025.174099_bb0650","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/jnc.13182","article-title":"Allosteric modulation of sigma-1 receptors by SKF83959 inhibits microglia-mediated inflammation","volume":"134","author":"Wu","year":"2015","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.pbb.2025.174099_bb0655","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1177\/02698811241249436","article-title":"Psilocybin promotes neuroplasticity and induces rapid and sustained antidepressant-like effects in mice","volume":"38","author":"Xiangting","year":"2024","journal-title":"J. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.pbb.2025.174099_bb0660","doi-asserted-by":"crossref","first-page":"584","DOI":"10.3390\/biomedicines11020584","article-title":"The serum brain-derived neurotrophic factor increases in serotonin reuptake inhibitor responders patients with first-episode, drug-naive major depression","volume":"11","author":"Yoshimura","year":"2023","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.pbb.2025.174099_bb0665","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41392-023-01519-z","article-title":"Epigenetic regulation in major depression and other stress-related disorders: molecular mechanisms, clinical relevance and therapeutic potential","volume":"8","author":"Yuan","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"6","key":"10.1016\/j.pbb.2025.174099_bb0670","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28062624","article-title":"The effect of combined treatment of psilocybin and eugenol on lipopolysaccharide-induced brain inflammation in mice","volume":"28","author":"Zanikov","year":"2023","journal-title":"Molecules"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305725001467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305725001467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T05:57:53Z","timestamp":1780120673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305725001467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":134,"alternative-id":["S0091305725001467"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2025.174099","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advancements in psychedelic research: Effects, mechanisms, and therapeutic potential as emerging antidepressants","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2025.174099","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"174099"}}